{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:05:03Z","timestamp":1790885103625,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.pnpbp.2011.11.007","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T19:07:50Z","timestamp":1322075270000},"page":"78-87","source":"Crossref","is-referenced-by-count":26,"title":["Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders"],"prefix":"10.1016","volume":"38","author":[{"given":"Susana","family":"Esteban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas A.","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.11.007_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","article-title":"Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids","volume":"68","author":"Alger","year":"2002","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1476-5381.2010.00710.x","article-title":"Regulation of Fas receptor\/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain","volume":"160","author":"\u00c1lvaro-Bartolom\u00e9","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","article-title":"Endocannabinoid system dysfunction in mood and related disorders","volume":"124","author":"Ashton","year":"2011","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","article-title":"The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets","volume":"12","author":"Bambico","year":"2008","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0030","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2174\/138161209788168029","article-title":"Endocannabinoids in the treatment of mood disorders: evidence from animal models","volume":"15","author":"Bambico","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nbd.2009.11.020","article-title":"Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission","volume":"37","author":"Bambico","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.euroneuro.2009.02.001","article-title":"Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain","volume":"19","author":"Barna","year":"2009","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1471-4159.1997.69031131.x","article-title":"Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum","volume":"69","author":"Cadogan","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0050","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1074\/jbc.M710300200","article-title":"Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors","volume":"283","author":"Canals","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1460-9568.2009.07054.x","article-title":"Cannabinoid modulation of limbic forebrain noradrenergic circuitry","volume":"31","author":"Carvalho","year":"2010","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0091-3057(91)90367-B","article-title":"THC does not affect striatal dopamine release: microdialysis in freely moving rats","volume":"40","author":"Castaneda","year":"1991","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-4522(00)00241-4","article-title":"Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study","volume":"99","author":"Cheer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0028-3908(03)00029-7","article-title":"Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum","volume":"44","author":"Cheer","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707506","article-title":"Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI","volume":"153","author":"Chin","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(03)00150-3","article-title":"Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover","volume":"75","author":"Darmani","year":"2003","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sciences"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0100","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1073\/pnas.95.17.10269","article-title":"Mesolimbic dopaminergic decline after cannabinoid withdrawal","volume":"95","author":"Diana","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(02)01755-7","article-title":"Involvement of 5-hydroxytryptamine neuronal system in delta9-tetrahydrocannabinol-induced impairment of spatial memory","volume":"445","author":"Egashira","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(03)00145-3","article-title":"Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid Signaling","volume":"119","author":"Egertov\u00e1","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00261435","article-title":"\u03b12-Autoreceptors and \u03b12-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the \u03b12-adrenoceptor subtypes","volume":"353","author":"Esteban","year":"1996","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0125","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.mce.2008.02.006","article-title":"Neurobiological mechanisms of cannabinoid addiction","volume":"286","author":"Fattore","year":"2008","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","article-title":"Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors","volume":"341","author":"Gessa","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0145","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0022-3565(25)13092-9","article-title":"Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 552122-2, and is potentiated by the cannabinoid antagonist, SR 141716A","volume":"277","author":"Gifford","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-2999(97)00082-4","article-title":"Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices","volume":"324","author":"Gifford","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0155","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0160","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.pnpbp.2010.11.021","article-title":"Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants","volume":"35","author":"Gorzalka","year":"2011","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0170","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0175","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00001756-199507100-00015","article-title":"The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat","volume":"6","author":"Gueudet","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0163-7258(02)00256-5","article-title":"Cannabinoids and cell fate","volume":"95","author":"Guzm\u00e1n","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1124\/jpet.109.153858","article-title":"Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 Receptors","volume":"331","author":"Haj-Dahmane","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"H\u00e4ring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1073858406296716","article-title":"Endocannabinoids and synaptic function in the CNS","volume":"13","author":"Hashimotodani","year":"2007","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","article-title":"Neuronal localization of cannabinoid receptors in the basal ganglia of the rat","volume":"547","author":"Herkenham","year":"1991","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocananiboid system in the etiology and treatment of melancholic depression?","volume":"16","author":"Hill","year":"2005","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0006-8993(82)91016-2","article-title":"Delta 9-tetrahydrocannabinol-induced changes in beta-adrenergic receptor binding in mouse cerebral cortex","volume":"235","author":"Hillard","year":"1982","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","article-title":"Upregulation of CB1 receptors and agonist-stimulated [35S]GTP\u03b3S binding in the prefrontal cortex of depressed suicide victims","volume":"9","author":"Hungund","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(99)02346-X","article-title":"The effect of serotonin1A receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens","volume":"858","author":"Ichikawa","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(97)00103-0","article-title":"Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro","volume":"755","author":"Jolas","year":"1997","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(03)00070-8","article-title":"Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia","volume":"119","author":"Juli\u00e1n","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/PL00005377","article-title":"Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate stimulated noradrenaline and dopamine release in the brain","volume":"359","author":"Kathmann","year":"1999","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0260","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(99)01062-8","article-title":"Tonic regulation of the activity of noradrenergic neurons in the locus coeruleus of the conscious rat studied by dual-probe microdialysis","volume":"823","author":"Kawahara","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0270","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tips.2011.02.013","article-title":"Personalized medicine can pave the way for the safe use of CB1 receptor antagonists","volume":"32","author":"Lazary","year":"2011","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0275","doi-asserted-by":"crossref","first-page":"36013","DOI":"10.1074\/jbc.M403990200","article-title":"Constitutive endocytic cycle of the CB1 cannabinoid receptor","volume":"279","author":"Leterrier","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0280","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0285","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1460-9568.2005.03930.x","article-title":"Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases","volume":"21","author":"Liu","year":"2005","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0702753","article-title":"Modulation by fluoxetine of striatal dopamine release following delta 9-tetrahydrocannabinol: a microdialysis study in conscious rats","volume":"128","author":"Malone","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0305","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(01)00723-3","article-title":"Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens","volume":"412","author":"Manzoni","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0310","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0315","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1192\/bjp.161.5.648","article-title":"Cannabis and psychotic illness","volume":"161","author":"Mathers","year":"1992","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0320","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/mol.109.060079","article-title":"Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms","volume":"77","author":"Mato","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0325","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cne.903270406","article-title":"Localization of cannabinoid receptor mRNA in rat brain","volume":"327","author":"Matsuda","year":"1993","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0330","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0278-5846(00)00119-6","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats","volume":"534","author":"Mendiguren","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuropharm.2006.09.004","article-title":"CB1 cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices","volume":"52","author":"Mendiguren","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0345","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1476-5381.2009.00434.x","article-title":"Effect of the CB1 receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices","volume":"158","author":"Mendiguren","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0355","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00210-004-0921-x","article-title":"Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain","volume":"369","author":"Moranta","year":"2004","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0360","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00210-008-0337-0","article-title":"Chronic treatment and withdrawal of the cannabinoid agonist WIN 55, 212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain","volume":"379","author":"Moranta","year":"2009","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0365","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.neuroscience.2007.11.016","article-title":"Involvement of subthalamic nucleus in the stimulatory effect of \u03949-tetrahydrocannabinol on dopaminergic neurons","volume":"151","author":"Morera-Herreras","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0370","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1460-9568.2006.04759.x","article-title":"Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons","volume":"23","author":"Muntoni","year":"2006","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0375","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0380","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0385","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2005.03.036","article-title":"Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex","volume":"1046","author":"Oropeza","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pbb.2006.12.020","article-title":"Repeated cannabinoid administration increases indices of noradrenergic activity in rats","volume":"86","author":"Page","year":"2007","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2007.11.009","article-title":"Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex","volume":"431","author":"Page","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","article-title":"The endocannabinoid system and psychiatric disorders","volume":"224","author":"Parolaro","year":"2010","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0415","series-title":"Constitutive activity of canabinoid CB1 receptors in major depression","author":"Pazos","year":"2006"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0420","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0425","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-6997(24)01417-0","article-title":"Autoregulation of serotonin neurons: role in antidepressant drug action","volume":"51","author":"Pi\u00f1eyro","year":"1999","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0430","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuroscience.2007.10.026","article-title":"M. \u03949-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons","volume":"151","author":"Sano","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0440","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.11.023","article-title":"Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors","volume":"1312","author":"Scavone","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0445","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0450","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/PL00005093","article-title":"Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus","volume":"356","author":"Schlicker","year":"1997","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0455","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuint.2007.07.014","article-title":"Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels","volume":"52","author":"Sidl\u00f3","year":"2008","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","article-title":"Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids","volume":"15","author":"Sim-Selley","year":"2003","journal-title":"Critical Reviews in Neurobiology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0465","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.105.019612","article-title":"Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration","volume":"70","author":"Sim-Selley","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0470","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1471-4159.2001.00484.x","article-title":"Presynaptic autoreceptors in the third decade: focus on \u03b12-adrenoceptors","volume":"78","author":"Starke","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","volume":"168","author":"Szabo","year":"2005","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0475","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.1999.0731084.x","article-title":"Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro","volume":"73","author":"Szabo","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0485","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0490","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0495","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bjp.0703305","article-title":"Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues","volume":"130","author":"Trendelenburg","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0500","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0306-4522(99)00086-X","article-title":"Cannabinoid CB1 receptors are localized primarily on cholecystokinin containing GABAergic interneurons in the rat hippocampal formation","volume":"93","author":"Tsou","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0510","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(01)01228-6","article-title":"The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus","volume":"426","author":"Tzavara","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0505","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0515","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","article-title":"Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment","volume":"206","author":"Urig\u00fcen","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0520","series-title":"Functionality of cannabinoid receptors in the prefrontal cortex of major depression suicide victims: influence of antidepressant treatment at the time of death","author":"Valdiz\u00e1n","year":"2011"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0525","first-page":"1","article-title":"CB1 receptor-deficient mice as a model for depression","volume":"204","author":"Valverde","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/3-540-26573-2_12","article-title":"Retrograde signalling by endocannabinoids","volume":"168","author":"Vaughan","year":"2005","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0540","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tips.2006.08.006","article-title":"Role of the endocannabinoid system in depression and suicide","volume":"27","author":"Vinod","year":"2006","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0535","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","article-title":"Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims","volume":"57","author":"Vinod","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0545","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0028-3908(99)00140-9","article-title":"Effects of chronic \u03949-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment","volume":"39","author":"Wu","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.007_bb0550","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T10:46:29Z","timestamp":1741949189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0278584611003368"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.11.007","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}